What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Polyrizon achieves major production milestone for PL-14 nasal spray as 2026 clinical trial preparation accelerates Polyrizon has successfully scaled production of its PL-14 intranasal hydrogel to clinical-trial grade, clearing a critical hurdle ahead of its planned 2026 human study. bySoujanya RaviDecember 2, 2025